methotrexate ( mtx ) was administered by continual intravenous infusion for 24 hours in doses ranging from 200-800 mg/m2 to 16 patients who had metastatic cancers and normal bone marrows and 11 patients with acute leukemia .
C0005953
bone marrows
C0085669
acute leukemia